首页> 外文期刊>Internal medicine journal >Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy
【24h】

Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy

机译:停止抗血栓治疗可将抗磷脂抗体综合征急性发展为严重的抗磷脂抗体综合征

获取原文
获取原文并翻译 | 示例
           

摘要

Catastrophic antiphospholipid antibody syndrome (CAPS) is a serious condition that is often unrecognised with a high mortality. Cessation of anticoagulation in antiphospholipid antibody syndrome (APS) can have devastating consequences with progression to CAPS. Making a diagnosis of APS can however be challenging because of the evolving diagnostic criteria and difficulty in confirming thromboses. Management of these patients can also be complex, especially in those with coexistent thrombocytopenia. New potential treatments are emerging targeted on the immunomodulation of APS rather than just prevention of thrombosis. This article aims to highlight these diagnostic and management difficulties by reporting and discussing three cases of APS with progression to CAPS following cessation of anticoagulation, one with fatal consequences, with confirmation of CAPS on autopsy, and two with successful treatment and outcomes.
机译:灾难性的抗磷脂抗体综合症(CAPS)是一种严重的疾病,通常不被认为具有很高的死亡率。抗磷脂抗体综合症(APS)停止抗凝治疗可能会导致严重后果,发展为CAPS。然而,由于不断发展的诊断标准和难以确定血栓形成,对APS的诊断可能具有挑战性。这些患者的治疗也可能很复杂,特别是在合并有血小板减少症的患者中。针对APS免疫调节的新的潜在治疗方法正在出现,而不仅仅是预防血栓形成。本文旨在通过报告和讨论3例在抗凝治疗停止后发展为CAPS的APS病例,强调其中的诊断和管理困难,其中1例具有致命后果,经尸检证实为CAPS,而2例具有成功的治疗和结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号